Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker-Reference-Cited by-同舟云学术

Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker

Published:2014-05-18 Issue:1 Volume:28 Page:15-21
ISSN:0895-7061
Container-title:American Journal of Hypertension
language:en
Short-container-title:American Journal of Hypertension

Author:

Furuhashi M.,Moniwa N.,Mita T.,Fuseya T.,Ishimura S.,Ohno K.,Shibata S.,Tanaka M.,Watanabe Y.,Akasaka H.,Ohnishi H.,Yoshida H.,Takizawa H.,Saitoh S.,Ura N.,Shimamoto K.,Miura T.

Publisher

Oxford University Press (OUP)

Subject

Internal Medicine

Link

http://academic.oup.com/ajh/article-pdf/28/1/15/8663983/hpu086.pdf

Reference42 articles.

1. A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9

2. Angiotensin-converting enzyme 2 is an essential regulator of heart function

3. The angiotensin–converting enzyme gene family: genomics and pharmacology

4. A Human Homolog of Angiotensin-converting Enzyme

5. Angiotensin-converting enzyme 2: implications for blood pressure and kidney disease

Cited by 225 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Angiotensin-Converting Enzyme 2 Expression In Vivo with Novel ⁶⁸Ga-Labeled Peptides Originated from the Coronavirus Receptor-Binding Domain;ACS Pharmacology & Translational Science;2024-09-12

2. Phytomedical compounds as promising therapeutic agents for COVID-19 targeting angiotensin-converting enzyme 2: a review;Journal of Pharmacy and Pharmacology;2024-07-17

3. Role of renin-angiotensin system/angiotensin converting enzyme-2 mechanism and enhanced COVID-19 susceptibility in type 2 diabetes mellitus;World Journal of Diabetes;2024-04-15

4. Developmental Impacts of Epigenetics and Metabolism in COVID-19;Journal of Developmental Biology;2024-02-09

5. Influence of angiotensin receptor and converting enzyme blockers therapy in the respiratory outcome of COVID-19 hospitalized patients;Medicina Clínica (English Edition);2024-02